BioLoomics is developing safer, more effective cancer medicines through innovative antibody solutions. Our mission is to engineer better antibody-drug conjugates with programmable trafficking activity. The BioLoomics discovery engine combines synthetic biology, robotics, imaging, and machine learning to perform a function-first search of antibody design space at ultra-high throughput. We are building a highly cross-functional team that will do cutting-edge drug discovery and development. We are a people first company.
The Impact of Your Work:
Successful execution by you and your team will lead to the discovery of novel antibody designs that will progress to the clinic…
Click here to view original post
